Download Report

Saturday, 7 February 2015
16.10 – 16.15 Opening and welcome
C.R. Chapple, Sheffield (GB)
J. Palou, Barcelona (ES)
16.15 – 18.00 What is new in urology 1
Chairs: C.R. Chapple, Sheffield (GB)
J. Palou, Barcelona (ES)
16.15 – 16.35 Functional urology
P. Abrams, Bristol (GB)
16.35 – 16.55 What’s new in renal cancer
H.G. Van Der Poel, Amsterdam (NL)
16.55 – 17.15 Recent developments in laparoscopy
A. Breda, Barcelona (ES)
17.15 – 17.35 What is new in endourology?
E. Liatsikos, Patras (GR)
17.35 – 18.00 Prostate cancer
A. Bjartell, Malmö (SE)
18.00 – 18.10 Coffee break
18.10 – 19.30 What is new in urology 2
Chair: J. Palou, Barcelona (ES)
18.10 – 18.30 Erectile dysfunction
W. Aulitzky, Vienna (AT)
18.30 – 18.50 Bladder cancer
N.W. Clarke, Manchester (GB)
18.50 – 19.10 Paediatric urology
J.M. Nijman, Groningen (NL)
19.10 – 19.30 Screening and treating prostate cancer in the elderly
J.C. Hu, LA (US)
19.30 – 21.00 Welcome cocktail
Sunday, 8 February 2015
07.30 – 08.45 An update on medical urology for the urooncologist
Chair: N.W. Clarke, Manchester (GB)
Participants:
P-A. Abrahamsson, Malmö (SE)
C. Stief, Munich (DE)
M. Wirth, Dresden (DE)
08.45 – 09.00 Coffee break
09.00 – 11.00 Urological challenge
Chair: F.M.J. Debruyne, Arnhem (NL)
Critique panel: P-A. Abrahamsson, Malmö (SE), T. Bach, Hamburg (DE),
N.W. Clarke, Manchester (GB), C. Stief, Munich (DE), M. Wirth, Dresden (DE)
Prostate cancer screening – current controversies
J. Dobruch, Warsaw (PL)
Antidiuresis in overactive bladder syndrome
H. Hashim, Bristol (GB)
90-day postoperative complications and hospital readmissions. An open vs.
robot-assisted radical prostatectomy comparison S. Tyritzis, Athens (GR) 11.00 – 11.30 “Minimally Invasive Percutaneous Stone Therapy: MIP 2.0 XS, S, M + L,
Downsizing is not enough”
U. Nagele, Hall inn (AT)
Industry sponsored 11.30 – 15.30 Video session 1
16.00 – 16.45 Update on new interventional management of urolithiasis
ESWL – J. Rassweiler, Heilbronn (DE)
URS – K. Sarica, Istanbul (TR)
PCNL – T. Bach, Hamburg (DE)
16.45 – 17.45 Functional urology cases
Chair: P. Abrams, Bristol (GB)
Participants:
D.M. Castro Diaz, Santa Cruz de Tenerife (ES)
C.R. Chapple, Sheffield (GB)
17.45 – 18.00 Coffee break
17.00 – 19.00 Hands-on training on URS
Tutors:
A. Breda, Barcelona (ES)
J-T. Klein, Heilbronn (DE)
T. Knoll, Sindelfingen (DE)
P.J. Osther, Fredericia (DK)
Industry sponsored
18.00 – 19.15 Urological challenge
Chair: F.M.J. Debruyne, Arnhem (NL)
Critique panel: P. Abrams, Bristol (GB), D.M. Castro Diaz, Santa Cruz de Tenerife (ES),
C.R. Chapple, Sheffield (GB), J. Rassweiler, Heilbronn (DE),
K. Sarica, Istanbul (TR)
Role of matrix metalloproteinases in urological tumours
O. Rodriguez Faba, Barcelona (ES) Fluorescence - Targeted pelvic lymph node dissection in prostate cancer - a true
(r)evolution?
S. Hruby, Salzburg (AT)
Monday, 9 February 2015
08.15 – 08.45 Complications of mesh and how to manage them
C.R. Chapple, Sheffield (GB)
08.45 – 09.00 Coffee break
09.00 – 11.00 Urological challenge
Chair: F.M.J. Debruyne, Arnhem (NL)
Critique panel: W. Aulitzky, Vienna (AT), A. Breda, Barcelona (ES), J.C. Hu, LA (US),
E. Liatsikos, Patras (GR), J. Palou, Barcelona (ES)
Targeted biopsy in prostate cancer - is the paradigm ready to change?
S. Hruby, Salzburg (AT)
Is ischemia the real enemy during partial nephrectomy? Results from the lab and
the operating room
S. Tyritzis, Athens (GR)
Urodynamics before stress incontinence surgery
H. Hashim, Bristol (GB) 11.00 – 15.30 Video Session 2
16.00 – 16.30 Critical evaluation of minimally invasive surgery for renal oncology
J.C. Hu, LA (US)
16.30 – 17.15 How to avoid complications and deal with them with radical prostatectomy
Moderator: W. Artibani, Verona (IT)
Participants:
A. Bjartell, Malmö (SE)
J. Palou, Barcelona (ES)
C. Stief, Munich (DE)
17.15 – 17.45 Testosterone replacement therapy – a contemporary update on its use in
Clinical Urology
W. Aulitzky, Vienna (AT)
17.00 - 19.00 Hands-on training on URS
Tutors:
A. Breda, Barcelona (ES)
J-T. Klein, Heilbronn (DE)
T. Knoll, Sindelfingen (DE)
P.J. Osther, Fredericia (DK)
Industry sponsored
17.45 – 18.00 Coffee break
18.00 – 19.15 Urological Challenge
Chair: F.M.J. Debruyne, Arnhem (NL)
Critique panel: W. Artibani, Verona (IT), T. Bach, Hamburg (DE), A. Bjartell, Malmö
(SE), C. Stief, Munich (DE), J.M. Nijman, Groningen (NL)
The role of early, second resection in bladder cancer
J. Dobruch, Warsaw (PL)
Predictive factors in T1G3 bladder cancer. Lessons learned
O. Rodriguez Faba, Barcelona (ES) Tuesday, 10 February 2015
07.30 – 08.15 Update on bladder cancer management
Chair: C. Stief, Munich (DE)
Participants:
N.W. Clarke, Manchester (GB)
J. Palou, Barcelona (ES)
08.15 – 08.45 Adjunct therapy for prostate cancer – has this come of age?
P- A. Abrahamsson, Malmö (SE)
08.45 – 09.00 Coffee break
09.00 – 11.00 Urological challenge
Chair: F.M.J. Debruyne, Arnhem (NL)
Critique panel: W. Aulitzky, Vienna (AT), A. Breda, Barcelona (ES)
D.M. Castro Diaz, Santa Cruz de Tenerife (ES), J.M. Nijman, Groningen (NL),
K. Sarica, Istanbul (TR),
Evolution of focal cryoablation for small renal masses. Selection of the patient to
optimize the results
O. Rodriguez Faba, Barcelona (ES)
Management of male stress incontinence: Male sling vs artificial urinary sphincter
H. Hashim, Bristol (GB)
The neobladder PENTAFECTA concept in the overall evaluation of robot-assisted
radical cystectomy with totally intracorporeal neobladder formation. S. S. Tyritzis,
Athens (GR)
11.00 – 15.30 Video session 3
16.00 – 16.30 Personalised medicine – an important new direction for urology
W. Artibani, Verona (IT)
16.30 – 17.00 Translational research in oncology
Chair: N.W. Clarke, Manchester (GB)
Participants:
A. Bjartell, Malmö (SE)
H. Van Der Poel, Amsterdam (NL)
17.00 – 18.00 Paediatric cases
J.M. Nijman, Groningen (NL)
18.00 – 18.15 Coffee Break
18.15 – 19.30 Urological challenge
Chair: F.M.J. Debruyne, Arnhem (NL)
Critique panel: P. Abrams, Bristol (GB), A. Bjartell, Malmö (SE), J.C. Hu, L.A. (US),
E. Liatsikos, Patras (GR), H.G. Van Der Poel, Amsterdam (NL)
Clinical value of extended pelvic lymph node dissection in prostate cancer
patients
J. Dobruch, Warsaw (PL)
Stone retention devices in ureteroscopy
S. Hruby, Salzburg (AT)
Faculty
P-A. Abrahamsson, Malmö (SE)
P. Abrams, Bristol (GB)
W. Artibani, Verona (IT)
W. Aulitzky, Vienna (AT)
T. Bach, Hamburg (DE)
A. Bjartell, Malmö (SE)
A. Breda, Barcelona (ES)
D.M. Castro Diaz, Santa Cruz de Tenerife (ES)
C.R. Chapple, Sheffield (GB)
N.W. Clarke, Manchester (GB)
F.M.J. Debruyne, Arnhem (NL)
J.C. Hu, LA (US)
E. Liatsikos, Patras (GR)
J.M. Nijman, Groningen (NL)
J. Palou, Barcelona (ES)
J. Rassweiler, Heilbronn (DE)
K. Sarica, Istanbul (TR)
C. Stief, Munich (DE)
H.G. Van Der Poel, Amsterdam (NL)
M. Wirth, Dresden (DE)
Challengers
J. Dobruch, Warsaw (PL)
S. Tyritzis, Athens (GR) O. Rodriguez Faba, Barcelona (ES) H. Hashim, Bristol (GB) S. Hruby, Salzburg (AT) Tutors
A. Breda, Barcelona (ES)
J-T. Klein, Heilbronn (DE)
T. Knoll, Sindelfingen (DE)
P.J. Osther, Fredericia (DK)